Company Profile

HINDUSTAN UNILEVER LTD.

NSE : HINDUNILVRBSE : 500696ISIN CODE : INE030A01027Industry : Household & Personal ProductsHouse : Hindustan Unilever - MNC
BSE2247.85-45.65 (-1.99 % )
PREV CLOSE (Rs.) 2293.50
OPEN PRICE (Rs.) 2288.30
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 52183
TODAY'S LOW / HIGH (Rs.)2243.00 2289.65
52 WK LOW / HIGH (Rs.)1649.7 2307.2
NSE2248.25 -43.9 (-1.92 % )
PREV CLOSE(Rs.) 2292.15
OPEN PRICE (Rs.) 2282.20
BID PRICE (QTY) 2248.25 (560 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 1555224
TODAY'S LOW / HIGH(Rs.) 2242.50 2289.95
52 WK LOW / HIGH (Rs.)1650 2308.2

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.01
Dividend Yield(%) 0.98
TTM EPS (Rs.) 31.21
P/E Ratio 72.02
Book Value (Rs.) 43.70
Face Value (Rs.) 1
MCap (Rs. in Mn) 4866172.78
Price/Earning (TTM) 64.25
Price/Sales (TTM) 12.41
Price/Book (MRQ) 51.44
PAT Margin (%) 15.79
ROCE (%) 116.06
Incorporation Year : 1933

Management Info :

Sanjiv Mehta - Chairman Sanjiv Mehta - Managing Director

Registered Office :

Address : Unilever House,B. D. Sawant Marg,Chakala, Andheri East,
Mumbai,
Maharashtra-400099

Phone : 022- 39832285 / 39832452

Website : www.hul.co.in

Registrar's Details : KFIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS More
01Feb02-01-2020$HUL to increase soaps prices by up to 6% in phased manner HUL to increase soaps prices

Hindustan Unilever (HUL) is planning to increase soaps prices by up to 6 per cent in a phased manner to offset the rising cost of palm oil. Prices of palm oil in the last six months have gone up by 25 to 30 per cent.

HUL is India’s largest Fast Moving Consumer Goods Company with a heritage of over 80 years in India and touches the lives of nine out of ten Indian households.

Hindustan Unilever (HUL) is planning to increase soaps prices b..
01Feb02-01-2020$Hindustan Unilever jumps on reporting 13% rise in Q3 consolidated net profit Hindustan Unilever jumps on

Hindustan Unilever is currently trading at Rs. 2083.20, up by 49.05 points or 2.41% from its previous closing of Rs. 2034.15 on the BSE.

The scrip opened at Rs. 2058.00 and has touched a high and low of Rs. 2088.35 and Rs. 2035.50 respectively. So far 17556 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 2187.00 on 31-Oct-2019 and a 52 week low of Rs. 1649.70 on 05-Apr-2019.

Last one week high and low of the scrip stood at Rs. 2088.35 and Rs. 2020.35 respectively. The current market cap of the company is Rs. 440355.24 crore.

The promoters holding in the company stood at 67.18%, while Institutions and Non-Institutions held 19.00% and 13.82% respectively.

Hindustan Unilever has reported a rise of 11.91% in its net profit at Rs 1616 crore for the quarter ended December 31, 2019 as compared to Rs 1444 crore for the same quarter in the previous year. Total income of the company increased by 2.94% at Rs 9948 crore for Q3FY20 as compared Rs 9664 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 12.99% in its net profit attributable to owners at Rs 1627 crore for the quarter ended December 31, 2019 as compared to Rs 1440 crore for the same quarter in the previous year. Total income of the company increased by 2.97% at Rs 10208 crore for Q3FY20 as compared Rs 9914 crore for the corresponding quarter previous year.

Hindustan Unilever is currently trading at Rs. 2083.20, up by 4..
01Feb02-01-2020$SMS Pharma, BASF India and IndoStar Capital Finance to see some action today SMS Pharma, BASF India and I

SMS Pharmaceuticals has successful completed EDQM audit at Bachupally API Facility, Hyderabad in the state of Telangana. The inspection was conducted on January 29 to 31, 2020.

BASF India’s Parent Company -- BASF SE, Germany has closed the acquisition of Solvay's polyamide business at a purchase price on cash and debt free basis amounting to EUR 1.3 billion.

Everstone Group has entered into an agreement whereby Brookfield Business Partners, together with its institutional partners will, upon closing of the transaction, invest Rs 1,450 crore in IndoStar Capital Finance through a combination of subscription to securities and purchase of shares from IndoStar Capital Mauritius and mandatory tender offer, and seek to acquire 40% interest in the business, depending upon the subscription to the mandatory tender offer.

Shilpa Medicare has received approval from Central Drugs Standard Control Organisation (CDSCO) -New Delhi to manufacture and market Lenvatinib capsules 4mg and 10mg in India. It is the first company to obtain Generic approval for Lenvatinib Capsules 4mg and 10mg in India.

Hindustan Unilever has reported a rise of 11.91% in its net profit at Rs 1616 crore for third quarter ended December 31, 2019 as compared to Rs 1444 crore for the same quarter in the previous year. Total income of the company increased by 2.94% at Rs 9948 crore for Q3FY20 as compared Rs 9664 crore for the corresponding quarter previous year.

Aurobindo Pharma’s joint venture company (JV) -- Eugia Pharma has received a final approval from the US Food & Drug Administration (USFDA) to manufacture and market Methotrexate tablets, 2.5 mg. Methotrexate tablets are generic version of Dava Pharmaceuticals’ Rheumatrex Tablets. The product will be launched in March 2020. The approved product has an estimated market size of $98 million for the twelve months ending December 2019.

Polycab India has incorporated a wholly owned subsidiary (WOS) company named Polycab USA LLC with effect from January 27, 2020. The company wants to expand its business in the overseas market and create its presence worldwide.

SMS Pharmaceuticals has successful completed EDQM audit at Bach..
01Feb02-01-2020$Appointment of Director Appointment of Director
inter alia, approved the following: 1. based on the recommendation of the Nomination and Remuneration Committee, approved the appointment of Dr. Ashish Sharad Gupta as Independent Director on the Board of the Company with effect from 31st January, 2020. Dr. Gupta is an entrepreneur, advisor and strategic angel investor. He co-founded Helion Advisors in 2006 and presently represents Helion Advisors, managing a corpus of $600 million across three funds. He also serves on the boards of several firms including lnfoedge, Simplilearn, and Workspot. 2.based on the recommendatin of the Nomination and Remuneration Committee. approved certain changes in the Management Committee of the Company. 3.have decided to seek the consent of Members of the Company by way of a Postal Ballot for appointment of Mr. Wilhelmus Uijen as the Whole-time Director of the Company. The Boad of Directors have also appointed Mr. S.N. Ananthaasubramanian,Practising Company Secretary,who has also given the consent to act as the scrutinizer, for conducting the postal nallot process.
inter alia, approved the following: 1. based on the recommendat..
31Jan01-31-2020$Hindustan Unilever reports 13% rise in Q3 consolidated net profit Hindustan Unilever reports 1

Hindustan Unilever has reported results for third quarter ended December 31, 2019.

The company has reported a rise of 11.91% in its net profit at Rs 1616 crore for the quarter under review as compared to Rs 1444 crore for the same quarter in the previous year. Total income of the company increased by 2.94% at Rs 9948 crore for Q3FY20 as compared Rs 9664 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 12.99% in its net profit attributable to owners at Rs 1627 crore for the quarter under review as compared to Rs 1440 crore for the same quarter in the previous year. Total income of the company increased by 2.97% at Rs 10208 crore for Q3FY20 as compared Rs 9914 crore for the corresponding quarter previous year.

Hindustan Unilever has reported results for third quarter ended..
Financials More
Rs. in Millions
QTR Dec 19 ANNUAL 19
Net Profit1616060360
Gross Profit 22290 85220
Operating Profit 2585093010
Net Sales 98080382240
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Galaxy Surfactants (BSE)
 1658.90 (1.38%)
M.Cap ( in Cr)
5881.59
Godrej Consumer Prod (BSE)
 630.55 (1.38%)
M.Cap ( in Cr)
64462.16
Jyothy Labs (BSE)
 135.35 (4.48%)
M.Cap ( in Cr)
4970.17
Sheela Foam (BSE)
 1669.75 (0.29%)
M.Cap ( in Cr)
8145.51
Pee Cee Cosma Sope (BSE)
 85.85 (4.89%)
M.Cap ( in Cr)
22.72
Shareholding Pattern More
PROMOTERS 67.18 %
FI/BANKS/INSURANCE 4.07 %
MUTUAL FUNDS/UTI 2.58 %
NON-INSTITUTION 13.82 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes